Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?
Fiche publication
Date publication
janvier 2016
Journal
International journal of surgery (London, England)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe, Pr MEYER Nicolas, Pr ROHR Serge, Dr ROMAIN Benoit, Pr BRIGAND Cécile
Tous les auteurs :
Delhorme JB, Dupont-Kazma L, Addeo P, Lefebvre F, Triki E, Romain B, Meyer N, Bachellier P, Rohr S, Brigand C
Lien Pubmed
Résumé
Selection of patients for resection of synchronous liver metastases (LM) and peritoneal carcinomatosis (PC) of colorectal cancer (CRC) remains a debated issue since morbidity of this surgery is not negligible. We aimed to define overall survival (OS) prognostic criteria in patients undergoing PC surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) and LM resection.
Mots clés
Adult, Aged, Antineoplastic Agents, administration & dosage, Carcinoma, secondary, Colorectal Neoplasms, drug therapy, Combined Modality Therapy, Cytoreduction Surgical Procedures, methods, Female, Hepatectomy, methods, Humans, Hyperthermia, Induced, methods, Liver Neoplasms, chemically induced, Male, Middle Aged, Multivariate Analysis, Peritoneal Neoplasms, secondary, Prognosis, Prospective Studies, Retrospective Studies, Survival Rate
Référence
Int J Surg. 2016 Jan;25:98-105